 BACKGROUND: Since tumor markers increased course many benign diseases, aim study verify also occurs course rheumatic diseases. MATERIALS METHODS: investigated incidence characteristics Tumor M2-PK EDTA-plasma 137 patients suffering rheumatic diseases. RESULTS: tumor M2-PK concentration increased 52 63 patients (82%) classical rheumatoid arthritis, 15 21 patients (71%) systemic lupus erythematosus, 14 17 patients (82%) seronegative spondylarthritis 13 28 patients miscellaneous rheumatic diseases (46%). Malignant neoplasm detected patients rheumatic diseases. CONCLUSION: results demonstrated EDTA-plasma concentrations Tumor M2-PK increased patients rheumatic diseases.